Vitamin D: effects on childhood health and disease

被引:36
作者
Abrams, Steven A. [1 ]
Coss-Bu, Jorge A. [2 ]
Tiosano, Dov [3 ]
机构
[1] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Sect Crit Care, Houston, TX 77030 USA
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; BONE-MINERAL DENSITY; RANDOMIZED CLINICAL-TRIAL; D DEFICIENCY; D SUPPLEMENTATION; D-RECEPTOR; SERUM; 25-HYDROXYVITAMIN-D; PEDIATRIC-PATIENTS; CYSTIC-FIBROSIS;
D O I
10.1038/nrendo.2012.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D is a key nutrient for both healthy children and those with chronic illnesses. Understanding its roles in health and disease has become one of the most important issues in the nutritional management of children. Formal guidelines related to nutrient requirements for vitamin D in healthy children, recommending dietary intakes of 400IU per day for infants and 600IU per day for children over 1 year of age, were released by the Institute of Medicine in November 2010. However, application of these guidelines to children with acute and chronic illnesses is less clear. In this Review, we consider major illness categories and specific examples of conditions in children that might be affected by vitamin D. This information can be used in developing both model systems of investigation and clinical trials of vitamin D in children with acute and chronic illnesses. Abrams, S. A. at al. Nat. Rev. Endocrinol. 9, 162-170 (2013); published online 5 February 2013; doi:10.1038/nrendo.2012.259
引用
收藏
页码:162 / 170
页数:9
相关论文
共 94 条
[31]   Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients [J].
Green, Deanna M. ;
Leonard, Amanda R. ;
Paranjape, Shruti M. ;
Rosenstein, Beryl J. ;
Zeitlin, Pamela L. ;
Mogayzel, Peter J., Jr. .
JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (02) :143-149
[32]   Prevalence of Low Bone Mass and Deficiencies of Vitamins D and K in Pediatric Patients With Cystic Fibrosis From 3 Canadian Centers [J].
Grey, Vijaylaxmi ;
Atkinson, Stephanie ;
Drury, Donna ;
Casey, Linda ;
Ferland, Guylaine ;
Gundberg, Caren ;
Lands, Larry C. .
PEDIATRICS, 2008, 122 (05) :1014-1020
[33]   Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs:: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo [J].
Griffin, MD ;
Lutz, W ;
Phan, VA ;
Bachman, LA ;
McKean, DJ ;
Kumar, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6800-6805
[34]  
Guyton A. C., 1991, TXB MED PHYSL, P889
[35]  
Halton J, 2009, J BONE MINER RES, V24, P1326, DOI [10.1359/JBMR.090202, 10.1359/jbmr.090202]
[36]   Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease [J].
Hari, Pankaj ;
Gupta, Nandita ;
Hari, Smriti ;
Gulati, Ashima ;
Mahajan, Puneet ;
Bagga, Arvind .
PEDIATRIC NEPHROLOGY, 2010, 25 (12) :2483-2488
[37]  
Hartikainen H, 2005, East Afr Med J, V82, P294
[38]   An update on vitamin D and human immunity [J].
Hewison, Martin .
CLINICAL ENDOCRINOLOGY, 2012, 76 (03) :315-325
[39]   DOES 1,25-DIHYDROXYVITAMIN-D PARTICIPATE IN THE REGULATION OF HORMONE-RELEASE FROM ENDOCRINE GLANDS [J].
HOCHBERG, Z ;
BOROCHOWITZ, Z ;
BENDERLI, A ;
VARDI, P ;
OREN, S ;
SPIRER, Z ;
HEYMAN, I ;
WEISMAN, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (01) :57-61
[40]   CALCIUM THERAPY FOR CALCITRIOL-RESISTANT RICKETS [J].
HOCHBERG, Z ;
TIOSANO, D ;
EVEN, L .
JOURNAL OF PEDIATRICS, 1992, 121 (05) :803-808